ASH Annual Meeting and Exposition brings you the highlights from the American Society of Hematology Annual Meeting and Exposition. Refer back to this page often to read the latest news from ASH, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

Brentuximab vedotin, nivolumab combination appears active for Hodgkin lymphoma

January 15, 2018
ATLANTA — A combination of brentuximab vedotin with nivolumab appeared tolerable and safe among patients with relapsed or refractory Hodgkin…
Meeting News

Engineered stem cells may provide ‘universal’ donor cells for sickle cell disease

January 11, 2018
ATLANTA — A panel of customized induced pluripotent stem cells may allow for more efficient and safe matching of blood for transfusions among…
Meeting NewsPerspective

Active surveillance shows benefit for rare Hodgkin lymphoma subtype

January 10, 2018
ATLANTA — Active surveillance appeared to be a feasible strategy for the management of nodular lymphocyte-predominant Hodgkin lymphoma…
Meeting News

Detecting minimal residual disease may act as ‘surrogate endpoint’ for drug approvals

January 9, 2018
ATLANTA — Research is ramping up to find the best way to detect minimal residual disease in patients with acute myeloid leukemia, according to…
Meeting News

Dasatinib, chemotherapy combination appears effective in pediatric patients with leukemia subtype

January 5, 2018
ATLANTA — The addition of dasatinib to imatinib plus chemotherapy conferred survival benefit and appeared safe in pediatric patients with…
Meeting News

Reduced transfusion frequency may increase hospice referral in leukemia patients

January 3, 2018
ATLANTA — Patients with leukemia are less likely to be referred to hospice toward the end of life than patients with solid tumors, but…
Meeting News

Minimal residual disease a ‘powerful’ predictor for AML relapse, survival

December 20, 2017
ATLANTA — Detection of molecular minimal
Meeting NewsPerspective

Home stem cell transplantation could lower infections, costs

December 19, 2017
ATLANTA — Patients who received autologous and allogeneic hematopoietic stem cell transplantation in their homes maintained their quality of…
Meeting NewsPerspective

Most adolescents, young adults with leukemia subtype treated with therapies meant for adults

December 15, 2017
ATLANTA — The number of adolescents and young adults with acute lymphoblastic leukemia treated with pediatric-inspired chemotherapy regimens…
Meeting NewsVideo

VIDEO: Studies may lead to ‘era’ where chemotherapy is not needed for lymphoma subtype

December 15, 2017
ATLANTA — Two long-term follow-up studies presented at the ASH Annual Meeting and Exposition may indicate a future where patients with mantle…

Meeting Calendar

ASH Annual Meeting and Exposition

December 1, 2018 - December 4, 2018

  • Location: San Diego, Calif.
  • Website